These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 23593732

  • 1. [Bactericidal effect of levofloxacin injection in combination with meropenem against Pseudomonas aeruginosa using an in vitro simulation model with a hollow fiber system].
    Uoyama S, Kanda H, Yoshida K, Hoshino K.
    Jpn J Antibiot; 2012 Dec; 65(6):355-63. PubMed ID: 23593732
    [Abstract] [Full Text] [Related]

  • 2. Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology.
    Visalli MA, Jacobs MR, Appelbaum PC.
    Antimicrob Agents Chemother; 1998 Apr; 42(4):953-5. PubMed ID: 9559819
    [Abstract] [Full Text] [Related]

  • 3. Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B.
    Lim TP, Lee W, Tan TY, Sasikala S, Teo J, Hsu LY, Tan TT, Syahidah N, Kwa AL.
    PLoS One; 2011 Apr; 6(12):e28177. PubMed ID: 22162759
    [Abstract] [Full Text] [Related]

  • 4. The combination of meropenem and levofloxacin is synergistic with respect to both Pseudomonas aeruginosa kill rate and resistance suppression.
    Louie A, Grasso C, Bahniuk N, Van Scoy B, Brown DL, Kulawy R, Drusano GL.
    Antimicrob Agents Chemother; 2010 Jun; 54(6):2646-54. PubMed ID: 20368395
    [Abstract] [Full Text] [Related]

  • 5. Bactericidal effect of levofloxacin on strains with equal susceptibility in an in vitro urinary bladder model.
    Takahashi S, Sano M, Nishimura M, Matsukawa M, Mikami M, Hirose T, Tsukamoto T.
    Chemotherapy; 1998 Jun; 44(5):337-42. PubMed ID: 9732150
    [Abstract] [Full Text] [Related]

  • 6. In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa.
    Yamada K, Yamamoto Y, Yanagihara K, Araki N, Harada Y, Morinaga Y, Izumikawa K, Kakeya H, Hasegawa H, Kohno S, Kamihira S.
    J Infect Chemother; 2012 Aug; 18(4):472-8. PubMed ID: 22215228
    [Abstract] [Full Text] [Related]

  • 7. Combination treatment with meropenem plus levofloxacin is synergistic against Pseudomonas aeruginosa infection in a murine model of pneumonia.
    Louie A, Liu W, VanGuilder M, Neely MN, Schumitzky A, Jelliffe R, Fikes S, Kurhanewicz S, Robbins N, Brown D, Baluya D, Drusano GL.
    J Infect Dis; 2015 Apr 15; 211(8):1326-33. PubMed ID: 25362196
    [Abstract] [Full Text] [Related]

  • 8. In vitro activities of ceftobiprole combined with amikacin or levofloxacin against Pseudomonas aeruginosa: evidence of a synergistic effect using time-kill methodology.
    Kresken M, Körber-Irrgang B, Läuffer J, Decker-Burgard S, Davies T.
    Int J Antimicrob Agents; 2011 Jul 15; 38(1):70-5. PubMed ID: 21514795
    [Abstract] [Full Text] [Related]

  • 9. [Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations].
    Ishii C, Kakuta M, Abe T, Fukuoka T, Inoue M.
    Jpn J Antibiot; 2002 Apr 15; 55(2):187-95. PubMed ID: 12071096
    [Abstract] [Full Text] [Related]

  • 10. The relationship between the daily dosage of the carbapenem meropenem (MEPM) and MEPM-resistant Pseudomonas aeruginosa.
    Harashima S, Kondo H, Nabeshima A, Shimoda M, Yamaji K, Horiuchi T, Shimono N, Ikematsu H.
    J Infect Chemother; 2008 Jun 15; 14(3):219-22. PubMed ID: 18574658
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.
    Oshima K, Nakamura S, Iwanaga N, Takemoto K, Miyazaki T, Yanagihara K, Miyazaki Y, Mukae H, Kohno S, Izumikawa K.
    Antimicrob Agents Chemother; 2017 Jan 15; 61(1):. PubMed ID: 27799201
    [Abstract] [Full Text] [Related]

  • 12. In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
    Piccoli L, Guerrini M, Felici A, Marchetti F.
    J Chemother; 2005 Aug 15; 17(4):355-60. PubMed ID: 16167512
    [Abstract] [Full Text] [Related]

  • 13. Post-antibiotic effect of levofloxacin and tobramycin alone or in combination with cefepime against Pseudomonas aeruginosa.
    Ozbek B, Otuk G.
    Chemotherapy; 2009 Aug 15; 55(6):446-50. PubMed ID: 19996590
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Evaluation of antibiotics by the method of initial bactericidal activity].
    Matsuda K, Inoue M.
    Jpn J Antibiot; 2000 Dec 15; 53(12):667-71. PubMed ID: 11234223
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The antibacterial activity of levofloxacin eye drops against staphylococci using an in vitro pharmacokinetic model in the bulbar conjunctiva.
    Suzuki T, Yamamoto T, Ohashi Y.
    J Infect Chemother; 2016 Jun 15; 22(6):360-5. PubMed ID: 27036073
    [Abstract] [Full Text] [Related]

  • 20. Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.
    Lister PD, Wolter DJ.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S105-14. PubMed ID: 15712098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.